EXPD vs PTGX · P/E 26, rev $6.29B vs rev $269.8M
Expeditors International of Washington, Inc. (EXPD) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2026-06-30 was $6.29B. Net income was $495.8M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the EXPD and PTGX stock pages for the full models.
Not investment advice.